Would you like to contribute to this site?
IBS Menu
Submit an Article
Submit a Tip
Place your Ad
Add URL
IBS Questions?
Contact Us
Related Topics:
Constipation Predominant Ibs
Ibs And Constipation
Ibs Constipation
Ibs Constipation Diet
Ibs Constipation Symptoms
Ibs Constipation Treatment
Ibs With Constipation
Irritable Bowel Constipation
Irritable Bowel With Constipation
Ibs C
C Ibs
Constipation
Culturelle Ibs Constipation Type
Other Channels:
|
 |
|
|
|
|
|
|
|
|
Recent Questions and Answers
|
|
|
|
|
|
|
|
Recent Ibs Constipation News:
|
|
|
GIA announces the release of a comprehensive global report on Irritable Bowel Syndrome (IBS) Therapeutics markets. The global market for Irritable Bowel Syndrome (IBS) Therapeutics is forecast to reach $1.47 billion by the year 2017. The market for IBS therapeutics is presently driven by the high degree of unmet therapeutic needs, high penetration of generic drugs, and under diagnosis of the ...
Ironwood Pharmaceuticals Inc. Posted on:11 Aug 11 Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today provided an update on its second quarter 2011 and recent business activities.
Irritable bowel syndrome, or IBS, can be anywhere from annoying to downright debilitating making everyday situations fraught with anxiety. Millions suffer from IBS, which can cause on-going constipation, diarrhea, gas, bloating or any combination of the above.
Ardelyx, Inc. today announced it has closed a Series B preferred stock financing of $30.0 million. P...
Salix and Progenics are looking to get Relistor approved for use in chronic non-cancer pain patients with opioid-induced constipation. The FDA has assigned an action date of April 27, 2012.
| |
| |
|
|
|
Additional Ibs Constipation Resources:
|
|
|
|
|
|
|
|
|
Want your site featured on this page?
|
|
 |
|